Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C

por Lacy, B E, Lembo, A J, MacDougall, J E, Shiff, S J, Kurtz, C B, Currie, M G, Johnston, J M
Publicado 2014

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders

por Tack, J, Camilleri, M, Chang, L, Chey, W D, Galligan, J J, Lacy, B E, Müller-Lissner, S, Quigley, E M M, Schuurkes, J, Maeyer, J H, Stanghellini, V
Publicado 2012